Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Acq. announced Appointed director
|
BIOMARIN PHARMACEUTICAL INC (BMRN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
02/11/2022 |
5
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/11/2022 |
5
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/12/2021 |
5
| Mueller Brian (EVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/11/2021 |
5
| Acosta Andrea (GVP, Chief Accouning Officer) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/13/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
02/13/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
02/14/2018 |
5
| Davis George Eric (EVP, General Counsel) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/14/2018 |
5
| Mueller Brian (SVP, Corporate Controller) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/14/2018 |
5
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/14/2018 |
5
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/14/2017 |
5
| Mueller Brian (SVP, Corporate Controller) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/12/2016 |
5
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/15/2013 |
5
| BAFFI ROBERT (EVP, Technical Operations) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/25/2010 |
5
| Cooper Jeffrey H (SVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/25/2010 |
5
| ASELAGE STEVE (EVP, Chief Business Officer) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/12/2009 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
02/12/2009 |
5
| ASELAGE STEVE (SVP, Global Commercial Dev) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
01/10/2008 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
01/10/2008 |
5
| BAFFI ROBERT (SVP, Technical Operations) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
01/10/2008 |
5
| Cooper Jeffrey H (SVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
02/11/2005 |
5
| URQUHART JOHN (Director) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
|
|